Allergic rhinitis and asthma connection: Treatment implications
- 1 November 2008
- journal article
- research article
- Published by Oceanside Publications Inc. in Allergy and Asthma Proceedings
- Vol. 29 (6) , 557-564
Abstract
Treatment of patients with allergic rhinitis and asthma involves securing accurate diagnoses, avoidance measures, pharmacotherapy, and in some patients allergen immunotherapy, with consideration of immunomodulator therapy. At least 20% of patients with asthma have evidence of gastroesophageal reflux (GERD) and others have laryngeal pharyngeal reflux (LPR) also referred to as supraesophageal reflux (SERD) or “atypical reflux.” The scientific foundation of subcutaneous allergen immunotherapy (SCIT) includes generation of T-reg cells, which generate IL-10 and TGF-beta and suppress TH2 and TH1 lymphocyte responses. SCIT alone or even to a greater degree with omalizumab has been shown to reduce the extent of “facilitated allergen presentation” of allergen-IgE complexes binding to B lymphocytes, with the implication of reducing the extent of allergen presentation by B lymphocytes to T lymphocytes. In viewing the concept of the unified airway and the multiple approaches required for optimal patient care, asthma should be considered as a syndrome, which includes the concomitant conditions of allergic rhinitis and GERD (SERD or LPR) with the possibility of intermittent or chronic rhinosinusitis.Keywords
This publication has 29 references indexed in Scilit:
- Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: A longitudinal studyJournal of Allergy and Clinical Immunology, 2007
- Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen bindingJournal of Allergy and Clinical Immunology, 2007
- Allergen immunotherapy: A practice parameter second updateJournal of Allergy and Clinical Immunology, 2007
- Real-world Evaluation of Asthma Control and Treatment (REACT): Findings from a national Web-based surveyJournal of Allergy and Clinical Immunology, 2007
- Mechanisms of allergen-specific immunotherapyJournal of Allergy and Clinical Immunology, 2007
- Sublingual immunotherapy: A comprehensive reviewJournal of Allergy and Clinical Immunology, 2006
- Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitisJournal of Allergy and Clinical Immunology, 2006
- IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: Effect of immunotherapyJournal of Allergy and Clinical Immunology, 2005
- Omalizumab-induced reductions in mast cell FcεRI expression and functionJournal of Allergy and Clinical Immunology, 2004
- Omalizumab treatment downregulates dendritic cell FcεRI expressionJournal of Allergy and Clinical Immunology, 2003